scholarly journals A “strange” case of COPD

2015 ◽  
Vol 4 (3S) ◽  
pp. 63-66
Author(s):  
Laura Massarelli ◽  
Valerio Tomaselli ◽  
Carlo Bussolino ◽  
Valter Saracco
Keyword(s):  
Celiac Disease ◽  
Respiratory Tract ◽  
Bacterial Infections ◽  
B Lymphocyte ◽  
Inflammatory Diseases ◽  
Organ Damage ◽  
Positive Influence ◽  
Lymphoid Organ ◽  
The Body ◽  
Recurrent Infections

Common variable immunodeficiency (CVID) is a rare syndrome, characterized by hypogammaglobulinemia and limited antibody responses due to either impaired B-lymphocyte development or B-cell responses to T-lymphocyte signals. CVID is frequently associated with bacterial infections, particularly against respiratory tract, that could determine a permanent organ damage (COPD, asthma), increased incidence of both autoimmune diseases and cancer, high prevalence of gastrointestinal inflammatory diseases (ulcerative colitis, Crohn’s disease, celiac disease), lymphoproliferative and granulomatous diseases. Given that the gastrointestinal tract is the largest lymphoid organ in the body, it’s not surprising that intestinal diseases are common in immunodeficiency. CVID is considered a congenital condition but it is usually diagnosed in adulthood. We describe the case of a 43-year-old man affected by recurrent infections of respiratory tract with CVID, celiac disease and type 1 diabetes. With the exclusion of gluten from the diet, patient achieved an improvement of serum level of immunoglobulins and a reduction of recurrent infections. This fact suggests that the interruption of the gluten stimulus could have a positive influence on the other diseases, improving the metabolic compensation and stabilizing the immune system.

scholarly journals 335 The Gut-Lung Axis: The Human Perspective

2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 69-70
Author(s):  
Michael Surette
Keyword(s):  
Respiratory Tract ◽  
Early Life ◽  
Inflammatory Diseases ◽  
Chronic Inflammatory Disease ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Targeted Interventions ◽  
Susceptibility To Infection ◽  
Airway Diseases ◽  
Asthma And Allergy

Abstract The human gastrointestinal tract is the largest immune organ in the body and consequently influences the overall immune state of all body sites. The gut also harbors the largest proportion of the microbiome. In early life, the maturation of the microbiome and immune system are closely entangled, forming a homeostatic system that imparts individuality and stability to the host microbiome. It is now well established that factors that affect early life gut microbiota modulate susceptibility to chronic inflammatory diseases, including airway diseases such as asthma and allergy. Despite this global influence of the gut on immune response in the lungs, local microbiome-immune interactions also shape the response and susceptibility to disease in the airways. The upper respiratory tract and lung microbiomes also contribute to acute and chronic airway diseases. Modulating the gut-lung axis as well as respiratory tract through microbiome-targeted interventions to promote health and reduce susceptibility to infection and chronic inflammatory disease may represent an effective strategy, particularly in early and late life.

scholarly journals Gut Microbiome and Organ Fibrosis

Nutrients ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 352
Author(s):  
Carolina F. F. A. Costa ◽  
Benedita Sampaio-Maia ◽  
Ricardo Araujo ◽  
Diana S. Nascimento ◽  
Joana Ferreira-Gomes ◽  
...  
Keyword(s):  
Gut Microbiome ◽  
Inflammatory Diseases ◽  
Adaptive Immune System ◽  
Organ Damage ◽  
Pathological Process ◽  
The Body ◽  
Intestinal Fibrosis ◽  
Immune Mediated ◽  
Major Player ◽  
Organ Fibrosis

Fibrosis is a pathological process associated with most chronic inflammatory diseases. It is defined by an excessive deposition of extracellular matrix proteins and can affect nearly every tissue and organ system in the body. Fibroproliferative diseases, such as intestinal fibrosis, liver cirrhosis, progressive kidney disease and cardiovascular disease, often lead to severe organ damage and are a leading cause of morbidity and mortality worldwide, for which there are currently no effective therapies available. In the past decade, a growing body of evidence has highlighted the gut microbiome as a major player in the regulation of the innate and adaptive immune system, with severe implications in the pathogenesis of multiple immune-mediated disorders. Gut microbiota dysbiosis has been associated with the development and progression of fibrotic processes in various organs and is predicted to be a potential therapeutic target for fibrosis management. In this review we summarize the state of the art concerning the crosstalk between intestinal microbiota and organ fibrosis, address the relevance of diet in different fibrotic diseases and discuss gut microbiome-targeted therapeutic approaches that are current being explored.

scholarly journals Modern possibilities of herbal medicine in the treatment of acute inflammatory diseases of the upper respiratory tract

2021 ◽  
pp. 127-133
Author(s):  
A. V. Gurov ◽  
A. V. Muzhichkova
Keyword(s):  
Phenolic Compounds ◽  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
The Body ◽  
Upper Respiratory Tract ◽  
Plant Materials ◽  
Pelargonium Sidoides ◽  
Medicinal Substances ◽  
Upper Respiratory ◽  
Tract Infections

The article provides data on the effectiveness of the use of the drug in the treatment of acute, chronic and recurrent diseases of the respiratory tract and ENT organs. The drug is an extract of Pelargonium sidoides. From the standpoint of modern pharmacology, it is known that the use of natural products based on plant materials ensures safety and the absence of pronounced side effects. The main active ingredients of pelargonium are phenolic compounds: coumarins, flavonoids and phenolic acids. The article details the biochemical and pharmacological properties of each of the above groups of compounds. It has been shown that the presence of several classes of phenolic compounds simultaneously contributes to the potentiation of the pharmacological effects of each group separately. Therefore, drug has a pronounced polytropic effect: antiviral, antibacterial, immunomodulatory, mucolytic, anti-inflammatory, antioxidant, cytoprotective. The article presents the results of numerous domestic and foreign randomized, placebo-controlled studies demonstrating its high efficacy and safety in the treatment of ENT diseases, upper respiratory tract infections and bronchitis, not only in adults, but also in children over 1 year old. On the basis of the analyzed and presented material, the authors concluded that the use of a natural-based drug in the treatment of acute respiratory infection is effective and safe, both as monotherapy and in combination with other medicinal substances. He is able to quickly eliminate not only the symptoms of inflammation, but also to support the body with any ailments of this type.

scholarly journals Phage therapy in the treatment of patients with respiratory pathology: history, modern aspects, prospects

2021 ◽  
pp. 83-91
Author(s):  
G. N. Nikiforova ◽  
G. G. Asriyan ◽  
M. M. Gurkova ◽  
P. S. Artamonova
Keyword(s):  
Respiratory Tract ◽  
Mucous Membrane ◽  
Bacterial Infections ◽  
Inflammatory Diseases ◽  
Respiratory Pathogens ◽  
Upper Respiratory Tract ◽  
Dna And Rna ◽  
Treatment And Prevention ◽  
Upper Respiratory ◽  
Effective Use

Bacteriophages - viruses infecting bacteria are the largest known group of viruses, which in their structure mainly have doublestranded genomic DNA, but among them there are also groups with double-stranded RNA and single-stranded DNA and RNA. The total population is about 1031–1032 phages, they play an essential role in the regulation of the world’s number of bacteria. The rather complex and diverse interaction of these representatives of the microcosm continues throughout the history of their existence on our planet. The question of the use of bacteriophages in the treatment of patients with various bacterial infections still remains completely unexplored. The very idea of using these microorganisms for therapeutic purposes dates back to the First World War, when the French biologist and researcher Felix d’Hérelle discovered a special type of «bacteria-eating» viruses, on the basis of which he created drugs for the treatment of patients with dysentery. To date, a fairly large clinical experience has been accumulated in the use of phage preparations in the treatment of infectious and inflammatory diseases of the respiratory, gastrointestinal, urogenital tract, as well as in the therapy and prevention of purulent-septic processes and nosocomial infections. The mucous membrane of the upper respiratory tract is the first line of defense against various respiratory pathogens. The ability of bacteriophages to attach to the surface layer of mucus - mucin, forming an antibacterial protection of the mucous membrane and thus reducing the level of colonization of mucus by bacterial pathogens, determines their effective use in the treatment and prevention of inflammatory diseases of the upper respiratory tract. Due to certain unique properties of bacteriophages, peculiarities of vital activity and interaction with a bacterial cell, their use seems to be promising for the treatment of patients with infectious diseases of the upper respiratory tract.

scholarly journals Physical phenotype of blood cells is altered in COVID-19

2021 ◽  
Author(s):  
Markéta Kubánková ◽  
Bettina Hohberger ◽  
Jakob Hoffmanns ◽  
Julia Fürst ◽  
Martin Herrmann ◽  
...  
Keyword(s):  
Blood Cells ◽  
Inflammatory Diseases ◽  
Vascular Occlusion ◽  
Cell Types ◽  
Organ Damage ◽  
Clinical Syndrome ◽  
The Body ◽  
Physical Parameters ◽  
Physical Changes

Clinical syndrome coronavirus disease 2019 (COVID-19) induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by rapid spreading and high mortality worldwide. While the pathology is not yet fully understood, hyper-inflammatory response and coagulation disorders leading to congestions of microvessels are considered to be key drivers of the still increasing death toll. Until now, physical changes of blood cells have not been considered to play a role in COVID-19 related vascular occlusion and organ damage. Here we report an evaluation of multiple physical parameters including the mechanical features of five frequent blood cell types, namely erythrocytes, lymphocytes, monocytes, neutrophils, and eosinophils. More than 4 million blood cells of 17 COVID-19 patients at different levels of severity, 24 volunteers free from infectious or inflammatory diseases, and 14 recovered COVID-19 patients were analyzed. We found significant changes in erythrocyte deformability, lymphocyte stiffness, monocyte size, and neutrophil size and deformability. While some of these changes recovered to normal values after hospitalization, others persisted for months after hospital discharge, evidencing the long-term imprint of COVID-19 on the body.

scholarly journals Using of topical bacterial lysates in modern clinical practice

2021 ◽  
pp. 49-56
Author(s):  
V. M. Svistushkin ◽  
G. N. Nikiforova ◽  
A. V. Zolotova ◽  
V. A. Stepanova
Keyword(s):  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
Human Microbiome ◽  
Allergic Diseases ◽  
The Body ◽  
Economic Consequences ◽  
Medical Community ◽  
Side Reactions ◽  
Upper Respiratory Tract ◽  
Bacterial Lysates

Acute and chronic infectious and inflammatory diseases of the upper respiratory tract occupy a leading position in the structure of the pathology of the world’s population and remain the most frequent reason for patients seeking medical care. The prevalence and frequency of this disease in this nosological group makes a decisive contribution to the structure of the causes of temporary disability, which entails significant negative social and economic consequences. In this aspect, the spread of resistance of pathogens to etiotropic drugs and the insufficient arsenal of pathogenetic drugs stimulate the medical community to search for alternative approaches to the treatment of patients with respiratory pathology. One of these therapeutic areas is the use of immunomodulators, the most commonly used group of which are bacterial lysates. In the modern literature, sufficiently convincing data have been accumulated on the effectiveness of the use of bacterial lysates of systemic action, as a result of which the immune cells of the gastrointestinal tract are activated, which in turn leads to the restoration of autoregulation of the immune response throughout the body, and a decrease in the frequency of infectious and allergic diseases. The latest developments of domestic pharmacologists are topical bacterial lysates, the principle of which is based on the local activation of mucosal immunity in the respiratory tract. The undoubted advantage is that bacterial lysates, with all their effectiveness, do not harm the human microbiome, practically do not cause side reactions, combine well with other drugs, and can also be used at any stage of the disease, including for prophylactic purposes.

scholarly journals Several studies on the problem of management patients with chronic tonsillitis during periods of remission and exacerbation

2020 ◽  
pp. 109-115
Author(s):  
A. Yu. Ovchinnikov ◽  
N. A. Miroshnichenko ◽  
Yu. O. Nikolaeva ◽  
M. M. Vasilyev
Keyword(s):  
Respiratory Tract ◽  
Randomized Clinical Trials ◽  
Inflammatory Diseases ◽  
Allergic Diseases ◽  
Lymphatic Drainage ◽  
The Body ◽  
Chronic Tonsillitis ◽  
Upper Respiratory Tract ◽  
Bacterial Strains ◽  
Upper Respiratory

Increase in the number of acute and chronic diseases is a global trend. On the one hand, the emergence of new types of viruses, their active mutation, an increase in antibiotic-resistant bacterial strains, a high frequency of immunodeficiency and allergic diseases contribute to this. On the other hand is inadequate treatment of inflammatory diseases of the upper respiratory tract, widespread use of systemic antibiotics without indications. The use of bioregulatory medicines with proven efficacy in the complex treatment can reduce the drug load on the body, reduce the bacterial complications and side effects. Traumeel®S joins the physiological course of inflammation and activates pro-resolving mediators, contributes to its faster completion and tissue repair. The efficacy and safety of Traumeel®S has been confirmed in many randomized clinical trials. The drug has proven its value in almost any inflammatory pathology of the upper respiratory tract and ear. The drug Lymphomyosot®, a multicomponent agent with lymphatic drainage action, has proven itself perfectly in the complex therapy of chronic tonsillitis. In November 2019, the Council of Experts of the National Medical Association of Otorhinolaryngologists on the problems of pathology of the lympharyngeal ring was held. It is recommended to use the multicomponent bioregulatory preparation Traumeel®S to correct the inflammatory process, which has shown in studies a modulating effect on inflammatory mediators without suppressing COX-2 (prostaglandins). With exacerbation of chronic tonsillitis and lymphadenitis of nonspecific etiology, it is possible to use the multicomponent preparation Lymphomyosot®, which helps to improve the drainage and detoxification function of the lymphatic system.

scholarly journals Human Neutrophil Lipocalin in Activated Whole Blood Is a Specific and Rapid Diagnostic Biomarker of Bacterial Infections in the Respiratory Tract

2017 ◽  
Vol 24 (7) ◽  
Author(s):  
Per Venge ◽  
Ann-Katrin Eriksson ◽  
Lena Douhan-Håkansson ◽  
Karlis Pauksen
Keyword(s):  
Respiratory Tract ◽  
Whole Blood ◽  
Human Neutrophil ◽  
Bacterial Infections ◽  
Diagnostic Performance ◽  
Respiratory Tract Infections ◽  
Clinical Symptoms ◽  
Respiratory Infections ◽  
The Body ◽  
Tract Infections

ABSTRACT The distinction between bacterial and viral causes of infections of the respiratory tract is a major but important clinical challenge. We investigated the diagnostic performance of human neutrophil lipocalin (HNL) in respiratory tract infections compared to those of C-reactive protein (CRP) and procalcitonin (PCT). Patients were recruited from the emergency department and from a primary care unit (n = 162). The clinical diagnosis with regard to bacterial or viral cause of infection was complemented with objective microbiological/serological testing. HNL was measured in whole blood after preactivation with the neutrophil activator formyl-methionine-leucine-phenylalanine (fMLP) (B-HNL), and CRP and PCT were measured in plasma. Head-to-head comparisons of the three biomarkers showed that B-HNL was a superior diagnostic means to distinguish between causes of infections, with areas under the concentration-time curve (AUCs) of receiver operating characteristic (ROC) analysis for HNL of 0.91 (95% confidence interval [CI], 0.83 to 0.96) and 0.92 (95% CI, 0.82 to 0.97) for all respiratory infections and for upper respiratory infections, respectively, compared to 0.72 (95% CI, 0.63 to 0.80) and 0.68 (95% CI, 0.56 to 0.79) for CRP, respectively (P = 0.001). In relation to major clinical symptoms of respiratory tract infections (cough, sore throat, stuffy nose, and signs of sinusitis), AUCs varied between 0.88 and 0.93 in those patients with likely etiology (i.e., etiology is likely determined) of infection, compared to 0.63 and 0.71 for CRP, respectively, and nonsignificant AUCs for PCT. The diagnostic performance of B-HNL is superior to that of plasma CRP (P-CRP) and plasma PCT (P-PCT) in respiratory tract infections, and the activity specifically reflects bacterial challenge in the body. The rapid and accurate analysis of HNL by point-of-care technologies should be a major advancement in the diagnosis and management of respiratory infections with respect to antibiotic treatment.

scholarly journals Pengaruh Infusa Daun Sambiloto (Andrographis paniculata Nees) Terhadap Pertumbuhan Bakteri Shigella dysenteriae Secara In Vitro

2014 ◽  
Vol 1 (1) ◽  
pp. 29 ◽  
Author(s):  
Fitri Nadifah ◽  
Siti Fatimah ◽  
Indah Yuliana Barekola Lamablawa
Keyword(s):  
Traditional Medicine ◽  
Analysis Data ◽  
Organ Damage ◽  
Positive Influence ◽  
The Body ◽  
Andrographis Paniculata ◽  
Shigella Dysenteriae ◽  
Diffusion Method ◽  
Bowel Movements

Background: Bacteria Shigella dysenteriae is pathogenic bacterium which cause diarrheal diseases that enter into inside the body through intestine. Shigella dysenteriae constitute one of the gram negative bacterium which causes inflammation on intestinal, pain abdominal, tenesmus, and a bowel movements which accompanied with blood and mucus. Bad impact irational use of synthethic drugs and antibiotics can cause organ damage and germs resistance. Utilization of herbs as traditional medicine evolving rapidly and alternatively used by most. Traditional medicine has relatively low of side effect and affordable prices. Sambiloto (Andrographis paniculata Nees) is a plant which is ordinary used as a traditional medicine that can easily found around Indonesian islands. Sambiloto constitute one of the medicinal plants which is allegedly has the antibacterial effect because its chemical content of flavonoid saponins and tannin. The objective of this study is to know the influence of sambiloto (Andrographis paniculata Nees) leaves infuse against the growth of Shigella dysenteriae bacteria. Method: This is an experimental research using diffusion method. Statistical test who used namely analysis of variant one road (One Way anova). Analysis data were done descriptively and statistically and presented with of tables or graphs. Results: There is influence of sambiloto leaf infusa (Andrographis paniculata Nees) against the growth of Shigella dysenteriae bacteria in vitro with a mean diameter zone of radical on concentrations the smallest 20% is 12 mm and the greatest concentration 100% is 24.3 mm. Conclusion: Infuse leaf has a strong and positive influence in inhibit the growth of bacteria Shigella dysenteriae bacterium.

scholarly journals Species composition of certain strains of microorganisms in the development of upper respiratory tract disease in agricultural workers

2021 ◽  
Vol 100 (11) ◽  
pp. 1261-1266
Author(s):  
Lyaylya M. Masyagutova ◽  
Lilia G. Gizatullina ◽  
Maxmuza K. Gainullina ◽  
Natalya V. Vlasova ◽  
Linara A. Rafikova ◽  
...  
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Respiratory Tract ◽  
Agricultural Production ◽  
Inflammatory Diseases ◽  
The Body ◽  
Antibacterial Drug ◽  
Upper Respiratory Tract ◽  
E Coli ◽  
Leading Role ◽  
Upper Respiratory

Introduction. Microbiocenosis is a self-regulating system of relationships between the body and microflora. Ensuring the technological process of agricultural production involves contact with conditionally pathogenic and pathogenic microflora. The spread of antibacterial drug resistance is a matter of concern. Materials and methods. There was studied the microbiocenosis of the upper respiratory tract in agricultural enterprises: in the absence of inflammatory diseases; the clinical picture of diseases of the ENT organs, and the susceptibility of the isolated strains to antibacterial drugs. Results. Working conditions of employees correspond to classes 3.1 - 3.3. Typical representatives are strains of Streptococcus, Staphylococcus, Micrococcus, Neisseria, Corynebacterium. The etiological share of S. Aureus, C. Albicans, E. Coli, Kl. Pneumoniae, Ps. Aeruginosa, predominates in the formation of inflammatory diseases. Staphylococcus are most susceptible to Cefotaxime and Sparfloxacin, followed by Cefepime, Levofloxacin and Amikacin. Strains of Kl. pneumoniae are susceptible to Cefotaxime and Sparfloxacin; strains of Pseudomonas aeruginosa - to Cefepime and Ceftazidim; C. Albicans and C. crusei - to Amphotericin B and Fluconazole. Conclusion. The complex industrial factors of agricultural production contributes to the violation of the ratio of microbial associations even against the background of clinical health, which is a risk factor for the development of inflammatory processes. S. Aureus strains; Candida Albicans; Klebsiella Pneumoniae play the leading role. Pseudomonas aeruginosa and E. Coli. The isolates demonstrate multidrug resistance to antimicrobial drugs.

Sign in / Sign up

Export Citation Format

Share Document